A purchasing scientist has two documents open for Long R3 IGF-1 from different sources. One quotes a molecular mass of about 9111 Da, the other about 9118 Da, and a third reference in a colleague’s notes says 7649. Are these three different materials, a typo, or the same compound described three ways? The answer turns out to be a compact lesson in what changes when an analyte stops behaving like a short peptide and starts behaving like a small protein.
Three numbers, three states of the molecule
Long R3 IGF-1 is built on mature insulin-like growth factor 1, a single 70-residue chain held together by three internal disulfide bonds, with an average mass near 7648.7 Da. The analog makes two changes. The “R3” refers to arginine replacing the glutamic acid at position 3. The “Long” refers to a 13-residue extension added at the N-terminus: Met-Phe-Pro-Ala-Met-Pro-Leu-Ser-Ser-Leu-Phe-Val-Asn. The result is an 83-residue chain.
| Figure quoted | What it describes |
|---|---|
| About 7648.7 Da | Unmodified IGF-1 (70 residues), not the analog |
| About 9117.6 Da | Long R3 IGF-1 with all six cysteines reduced (free thiols) |
| About 9111.5 Da | Long R3 IGF-1 with its three disulfide bonds formed |
So the scientist’s documents are not necessarily contradictory. The 7649 figure belongs to a different molecule. The two analog figures differ by the hydrogens lost when disulfides form, and a document that does not say which state it means has left out the most useful part of the statement. The compound itself is introduced in what is IGF-1 LR3.
The six-dalton check and its blind spot
Each disulfide bond joins two cysteine thiols and releases two hydrogen atoms. Three bonds release six, so the oxidized molecule is about six daltons lighter than the reduced chain. On a molecule of roughly 9100 Da, resolving a six-dalton difference is well within the reach of a competent intact mass measurement. That makes it a genuinely informative check: it tells you whether the disulfides have formed.
What it cannot tell you is whether they formed correctly. Six cysteines can be paired in fifteen different ways, and only one of those arrangements is the native one. Every mispaired version has the same atoms and therefore exactly the same mass. An intact mass that matches 9111.5 Da proves the molecule is fully oxidized; it says nothing about which cysteine is bonded to which.
This is the real dividing line between small-peptide and protein analysis. For a short linear peptide, the failure modes are mostly changes in composition, such as a missing or extra residue, which a mass spectrum catches well (see mass spectrometry for peptide identity). For an 83-residue molecule with three disulfides, the failure mode that matters most is a wrong three-dimensional connection, and mass is blind to it.
Methods that can see folding
- Peptide mapping. The protein is cut with a protease, and the fragments still joined by disulfide bonds are identified. This can show which cysteines are linked, and it is also the method that places a modification on a specific residue rather than just reporting a mass shift somewhere in the chain.
- High-resolution separation. Mispaired isoforms usually present different surfaces to a stationary phase, so a well-developed chromatographic method can often separate them even though their masses are identical.
- Reduced versus non-reduced electrophoresis. Running the same sample with and without a reducing agent shows whether disulfides are present and whether any of them link two separate molecules together.
- Size exclusion chromatography. Separation by hydrodynamic size is the usual way to measure dimers and larger aggregates, which a denaturing reverse-phase method may not reveal.
Reading a reverse-phase result on a small protein
A reverse-phase HPLC area percentage means something slightly different here. For a short peptide, the related species it counts are mostly composition variants from synthesis. For a disulfide-containing protein, the peaks around the main one may be conformational isoforms, and whether the method separates them at all depends on how it was developed. A broad or shouldered main peak therefore more often points to isoform heterogeneity than to a foreign contaminant.
The reverse is also worth keeping in mind. One sharp, symmetrical peak from a method that has never been shown to resolve disulfide isoforms is not proof that only one isoform is present. It is a narrower statement: under those conditions, nothing else eluted separately. The general principles are covered in reverse-phase HPLC and peptide purity. Battle Born publishes an independent reverse-phase HPLC result for each product, and for a molecule of this size it is best read as exactly that kind of narrower statement.
A free clue in the electrospray spectrum
Electrospray ionization of a protein around 9100 Da produces a series of multiply charged ions rather than a single peak. For Long R3 IGF-1, the ion carrying eight extra protons appears near m/z 1139.9 and the ten-charge ion near m/z 912.2; software combines the series to report the intact mass.
The distribution of charge states carries information of its own. A compact, folded protein exposes fewer basic sites to protonation and tends to show fewer, lower charge states. An unfolded chain spreads toward higher charges. An envelope skewed strongly toward high charge is therefore a hint that the material may not be compactly folded, obtained from the same spectrum that supplied the mass.
Where it comes from changes what can go wrong
A chain of 83 residues is typically produced by recombinant expression rather than by stepwise chemical synthesis. That changes the likely impurities. Deletion sequences from failed coupling steps, a staple concern for synthetic peptides, become less relevant. Host cell proteins, residual nucleic acid, truncated expression products and incorrect N-terminal processing become the relevant questions, and they are measured by different techniques from those used for short peptides.
A short checklist for evaluating documentation
- Is the stated mass near 9111.5 Da, and does the document say it is the oxidized form?
- Is there any evidence addressing disulfide pairing or folding, such as a peptide map or non-reduced electrophoresis?
- Is aggregate content addressed by size exclusion or a similar method?
- Is the reverse-phase purity figure read as a statement about that method’s resolution rather than about folding? The general reading of such documents is covered in the peptide certificate of analysis.
Questions
Why is the oxidized form lighter than the reduced form?
Forming each disulfide bond removes two hydrogen atoms. Three bonds remove six, about six daltons in total.
Can mass spectrometry detect misfolded Long R3 IGF-1?
Not from intact mass alone, because every disulfide arrangement has the same mass. Charge-state distribution can hint at unfolding, but pairing needs peptide mapping or a separation that resolves isoforms.
Is 7649 Da ever correct for this compound?
No. That figure belongs to unmodified 70-residue IGF-1, which lacks both the N-terminal extension and the position 3 substitution.
Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.